GENEVA, Jan. 20 -- LANTERN PHARMA INC. (1920 McKinney Ave, 7th FloorDallas, TX 7520) filed a patent application (PCT/US2025/037036) for "COMPANION DIAGNOSTIC FOR HYDROXYUREA METHYLACYLFULVENE THERAPY" on Jul 09, 2025. With publication no. WO/2026/015677, the details related to the patent application was published on Jan 15, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): BHATIA, Kishor (1920 McKinney Ave, 7th FloorDallas, TX 7520), KULKARNI, Aditya (1920 McKinney Ave, 7th FloorDallas, TX 7520), ZHOU, Jianli (1920 McKinney Ave, 7th FloorDallas, TX 7520)
Abstract: A companion diagnostic metho...